- Home
- TARA vs LFCR Comparison
TARA vs LFCR Comparison
Compare TARA & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | LFCR |
|---|---|---|
| Founded | N/A | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 236.1M | 190.9M |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | TARA | LFCR |
|---|---|---|
| Price | $2.76 | $6.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $25.71 | $6.75 |
| AVG Volume (30 Days) | ★ 740.0K | 351.2K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,948,000.00 | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $3.19 | $3.63 |
| 52 Week High | $7.82 | $8.98 |
Technical Indicators
Market Signals| Indicator | TARA | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 25.92 | 79.37 |
| Support Level | N/A | $4.25 |
| Resistance Level | $4.13 | $8.40 |
| Average True Range (ATR) | 0.22 | 0.18 |
| MACD | -0.06 | 0.28 |
| Stochastic Oscillator | 8.21 | 97.13 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.